{"id":4950,"date":"2018-12-21T17:55:12","date_gmt":"2018-12-21T21:55:12","guid":{"rendered":"http:\/\/www.sochob.cl\/web1\/?page_id=4950"},"modified":"2026-05-06T11:04:19","modified_gmt":"2026-05-06T15:04:19","slug":"guias-de-obesidad","status":"publish","type":"page","link":"https:\/\/www.sochob.cl\/web1\/guias-de-obesidad\/","title":{"rendered":"Gu\u00edas y Consensos de Obesidad"},"content":{"rendered":"

2026<\/strong><\/span><\/p>\n

Sarcopenic obesity: Call to action and nutritional agenda from the international clinical nutrition community<\/a><\/span><\/p>\n

International consensus on adolescent metabolic health: prevention of obesity and type 2 diabetes<\/a><\/span><\/p>\n

TOS\/OMA\/OAC Expert Guidance Statement on Obesity Pharmacotherapy: A Humbling Call to Action<\/span><\/a><\/p>\n

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease<\/span><\/a><\/p>\n

Consensus statement on obesity management in liver transplantation candidates<\/span><\/a><\/p>\n

Joint TOS\/OMA\/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach<\/span><\/a><\/p>\n

Documento de consenso sobre estilo de vida saludable<\/span><\/a><\/p>\n

Socioeconomic and Structural Barriers to Addressing Obesity in Communities: A Scientific Statement From the American Heart Association<\/span><\/a><\/p>\n

Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 – based therapies: An expert consensus statement using a modified Delphi approach<\/span><\/a><\/p>\n

2025<\/strong><\/span><\/p>\n

European Association for the Study of Obesity (EASO) position statement on the diagnosis and management of obesity in older adults<\/span><\/a><\/p>\n

EASO Position on the EU Cardiovascular Health Plan<\/span><\/a><\/p>\n

Current guidelines and future directions in comprehensive obesity assessment<\/span><\/a><\/p>\n

2025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies<\/span><\/a><\/p>\n

Gu\u00eda Espa\u00f1ola GIRO. Gu\u00eda espa\u00f1ola del manejo Integral y multidisciplinaR de la Obesidad en personas adultas<\/span><\/a><\/p>\n

International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity<\/a><\/p>\n

CARDIO Alliance Global Implementation Guidelines for the Management of Obesity – Focus on prevention and treatment of cardiometabolic disease<\/span><\/a><\/p>\n

American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity\/Adiposity-Based Chronic Disease \u2013 2025 Update<\/span><\/a><\/span><\/p>\n

Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update<\/span><\/a><\/p>\n

Consenso sobre el diagn\u00f3stico, tratamiento y seguimiento de ni\u00f1as, ni\u00f1os y adolescentes con sobrepeso y obesidad de la Sociedad Latinoamericana de Gastroenterolog\u00eda, Hepatolog\u00eda y Nutrici\u00f3n Pedi\u00e1trica: LASPGHAN-SOB<\/span><\/a><\/p>\n

EASO Position Statement: Women with Obesity across the Reproductive Life \u2013 Fertility, Preconception, Pregnancy, Postpartum, and Breastfeeding<\/span><\/a><\/p>\n

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity<\/span><\/a><\/p>\n

2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure:\u00a0A Report of the American College of Cardiology<\/span><\/span><\/a><\/p>\n

2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health:\u00a0A Report of the American College of Cardiology Solution Set Oversight Committee<\/span><\/span><\/a><\/p>\n

VA\/DOD Clinical Practice Guideline for Management of Overweight and Obesity<\/span><\/a><\/p>\n

Weight stigma and bias: standards of care in overweight and obesity\u20142025<\/span><\/a><\/p>\n

Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory\u00a0from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society<\/span><\/a><\/p>\n

Development of the European Association for the Study of Obesity (EASO) Grade-Based Framework on the Pharmacological Treatment of Obesity: Design and Methodological Aspects<\/span><\/a><\/p>\n

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation<\/span><\/a><\/p>\n

Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC<\/span><\/a><\/p>\n

Obesity management in primary care: A joint clinical perspective and expert review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) – 2025<\/span><\/a><\/p>\n

The Spanish GIRO guideline: a paradigm shift in the management of obesity in adults<\/span><\/a><\/p>\n

European recommendations from healthcare professionals and people living with obesity on safe practice for bariatric and metabolic surgery medical tourism: a modified Delphi consensus statement from EASO, IFSO-EC, and ECPO<\/span><\/a><\/p>\n

Compounded GLP-1 and Dual GIP\/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association<\/span><\/a><\/p>\n

American Society for Metabolic and Bariatric Surgery review of the body mass index<\/span><\/a><\/p>\n

Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction Guidance for Industry<\/span><\/a><\/p>\n

Position statement and guidelines about Endoscopic Sleeve Gastroplasty (ESG) also known as \u00abEndo-sleeve\u00bb<\/span><\/a><\/p>\n

National Institute for Health and Care Excellence. Overweight and obesity management (NICE guideline NG246). 2025<\/span><\/a><\/p>\n

Bariatric nutrition and evaluation of the metabolic surgical patient: Update to the 2022 Obesity Medicine Association (OMA) bariatric surgery, gastrointestinal hormones, and the microbiome clinical practice statement (CPS)<\/span><\/a><\/p>\n

Definition and diagnostic criteria of clinical obesity<\/span><\/a><\/p>\n

2024<\/strong><\/span><\/p>\n

American Society for Metabolic and Bariatric Surgery Review of Body Composition<\/span><\/a><\/p>\n

International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)<\/a><\/span><\/p>\n

Gu\u00edas de pr\u00e1ctica cl\u00ednica para la prevenci\u00f3n, el diagn\u00f3stico y el tratamiento de la obesidad. Actualizaci\u00f3n 2024<\/a><\/span><\/p>\n

Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period<\/span><\/span><\/a><\/span><\/p>\n

Position Statement of Italian Society of Obesity (SIO): Gestational Obesity<\/a><\/span><\/p>\n

A new framework for the diagnosis, staging and management of obesity in adults<\/span><\/a><\/p>\n

European Association for the Study of Obesity (EASO) Position Statement on Medical Nutrition Therapy for the Management of Individuals with Overweight or Obesity and Cancer<\/span><\/a><\/p>\n

Posicionamiento 2024 de las Gu\u00edas Diet\u00e9ticas SEEDO (Sociedad Espa\u00f1ola para el Estudio de la Obesidad)<\/span><\/a><\/p>\n

Cardiometabolic risk in children and adolescents with obesity: a position paper of the Italian Society for Pediatric Endocrinology and Diabetology<\/a><\/span><\/p>\n

Consensus on pharmacological treatment of obesity in Latin America<\/a><\/span><\/p>\n

Mexican Clinical Practice Guidelines for Adult Overweight and Obesity Management<\/span><\/a><\/p>\n

ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases<\/a><\/span><\/p>\n

Obesity and cardiovascular disease: an ESC clinical consensus statement<\/span><\/a><\/p>\n

Special considerations for the child with obesity: An Obesity Medicine Association (OMA) clinical practice statement (CPS) 2024.<\/span><\/a><\/p>\n

Interventions for High Body Mass Index in Children and Adolescents. US Preventive Services Task Force Recommendation Statement<\/span><\/a><\/span><\/p>\n

Implementation of Obesity Science Into Clinical Practice: A Scientific Statement From the American Heart Association<\/a><\/span><\/p>\n

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024<\/a><\/span><\/p>\n

Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus<\/a><\/span><\/p>\n

Clinical practice guidelines for the management of overweight and obesity published internationally: A scoping review<\/a><\/span><\/p>\n

2023<\/strong><\/span><\/p>\n

IFSO-Consensus-on-Definitions-and-Clinical-Practice-Guidelines-for-Obesity-Management\u2014an-International-Delphi-Study.<\/a><\/span><\/p>\n

Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation<\/a><\/span><\/p>\n

\u201cAnti-obesity medications\u201d or \u201cmedications to treat obesity\u201d instead of \u201cweight loss drugs\u201d \u2013 why language matters \u2013 an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM)<\/a><\/span><\/p>\n

Consensus on Current Landscape and Treatment Trends of Obesity in India for Primary Care Physicians<\/a><\/span><\/p>\n

Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023<\/a><\/span><\/p>\n

Obesity: identification, assessment and management. Clinical guideline NICE<\/span><\/a><\/span><\/p>\n

Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO-2022).<\/a><\/span><\/p>\n

Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon<\/a><\/span><\/p>\n

The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery<\/a>.<\/span><\/p>\n

American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity\/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity<\/a><\/span><\/p>\n

Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023<\/a><\/span><\/p>\n

Practical guideline on obesity care in patients with gastrointestinal and liver diseases<\/a><\/span><\/p>\n

The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference<\/a><\/span><\/p>\n

Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity<\/a><\/span><\/p>\n

Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity<\/a><\/span><\/p>\n

EASO and EFAD Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Children and Adolescents<\/a><\/span><\/p>\n

European Association for the Study of Obesity Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Adults Developed in Collaboration with the European Federation of the Associations of Dietitians<\/a><\/span><\/p>\n

2022<\/strong><\/span><\/p>\n

Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland<\/a><\/span><\/p>\n

2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery<\/a><\/span><\/p>\n

AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity<\/a><\/span><\/p>\n

Treatment of pediatric overweight and obesity: Position of the Academy of Nutrition and Dietetics based on an umbrella review of systematic reviews<\/a><\/span><\/p>\n

Nutrition and physical activity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022<\/span><\/span><\/a><\/span><\/p>\n

C<\/span>ancer and\u00a0<\/span>Obesity: An\u00a0Obesity\u00a0Medicine Association (OMA) Clinical Practice Statement (CPS) 2022<\/span><\/a><\/span><\/p>\n

Obesity definition, diagnosis, bias, stand<\/span><\/span>ard operating procedures (SOPs), and\u00a0telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022<\/span><\/span><\/a><\/span><\/p>\n

Assessment, differential diagnosis, and initial clinical evaluation of the pediatric patient with obesity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022<\/span><\/span><\/a><\/span><\/p>\n

Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement<\/a><\/span><\/p>\n

Obesity history, physical exam, laboratory, body composition, and energy expenditure: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022<\/span><\/a><\/span><\/p>\n

Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 update<\/a><\/span><\/p>\n

2021<\/strong><\/span><\/p>\n

Weight-loss strategies for prevention and treatment of hypertension: A Scientific Statement from the American Heart Association<\/a><\/span><\/p>\n

Dietary supplements and alternative therapies for obesity: A Perspective from The Obesity Society\u2019s Clinical Committee<\/a><\/span><\/p>\n

European guidelines for obesity management in adults with a very low-calorie ketogenic diet: A systematic review and meta-analysis<\/a><\/span><\/p>\n

Obesity and cardiovascular disease: A scientific statement from the American Heart Association<\/a><\/span><\/p>\n

Consensus on medical nutrition therapy for diabesity (CoMeND) in adults: A South Asian perspective<\/a><\/span><\/p>\n

AGA Clinical practice guidelines on intragastric balloons in the management of obesity<\/a><\/span><\/p>\n

2020<\/strong><\/span><\/p>\n

Obesity and COVID\u201019 in Latin America: A tragedy of two pandemics\u2014Official document of the Latin American Federation of Obesity Societies<\/a><\/span><\/p>\n

Obesity in adults: a clinical practice guideline<\/a><\/span><\/p>\n

Cirug\u00eda bari\u00e1trica en adolescentes con obesidad severa: Recomendaciones de la Rama de Nutrici\u00f3n, Sociedad Chilena de Pediatr\u00eda<\/a><\/span><\/p>\n

European Association for the Study of\u00a0Obesity Position Statement on the Global COVID-19 Pandemic<\/a><\/span><\/p>\n

Joint international consensus statement for ending stigma of obesity<\/a><\/span><\/p>\n

Proposal for a scientifically correct and medically actionable disease classification system (ICD) for obesity<\/a><\/span><\/p>\n

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity<\/a><\/span><\/p>\n

European-Society-of-Endocrinology-Clinical-Practice-Guideline-Endocrine-work-up-in-obesity<\/a><\/span><\/p>\n

2019<\/strong><\/span><\/p>\n

Metabolic and bariatric surgery for pediatric patients with severe obesity<\/a><\/span><\/p>\n

Obesity and hormonal contraception: an overview and a clinician\u2019s practical guide<\/a><\/span><\/p>\n

Pediatric metabolic and bariatric surgery evidence barriers and best practices<\/a><\/span><\/p>\n

The ABCD of obesity: An EASO position statement on a diagnostic term with clinical and scientific implications<\/a><\/span><\/p>\n

European practical and patient centred guidelines for adult obesity management in primary care<\/a><\/span><\/p>\n

Evaluation and Management of obesity hypoventilation syndrome. An Official American Thoracic Society Clinical Practice Guideline<\/a><\/span><\/p>\n

2018<\/strong><\/span><\/p>\n

ASMBS pediatric metabolic and bariatric surgery guidelines, 2018<\/a><\/span><\/p>\n

Clinical practice guideline for multicomponent behavioral treatment of obesity 2018<\/a><\/span><\/p>\n

Current guidelines for obesity prevention in childhood and adolescence 2018<\/a><\/span><\/p>\n

Diagnosis, treatment and prevention of pediatric obesity – consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics<\/a><\/span><\/p>\n

Guideline recommendations for obesity management<\/a><\/span><\/p>\n

Obesity management in adults. NICE 2018<\/a><\/span><\/p>\n

The Science of Obesity Management: An Endocrine Society Scientific Statement<\/a><\/span><\/p>\n

Obesity Management Task Force of the European Association for the Study of Obesity Released -practical recommendations for the post-bariatric surgery medical management<\/a><\/span><\/p>\n

2017<\/strong><\/span><\/p>\n

Obesity Pathogenesis: An Endocrine Society Scientific Statement<\/a><\/span><\/p>\n

Pediatric Obesity – Assessment, treatment, and prevention. An Endocrine Society Clinical Practice Guideline 2017<\/a><\/span><\/p>\n

Practical recommendations of the obesity management Task Force of the European Association for the Study of Obesity for the post-bariatric surgery medical management.<\/a><\/span><\/p>\n

Stigma experienced by children and adolescents with obesity<\/a><\/span><\/p>\n

2016<\/strong><\/span><\/p>\n

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical practice guidelines for comprehensive medical care of patients with obesity 2016<\/a><\/span><\/p>\n

American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update- Micronutrients<\/a><\/span><\/p>\n

Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese- Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. 2016<\/a><\/span><\/p>\n

2015<\/strong><\/span><\/p>\n

2015-OMTF-European-guidelines-for-obesity-management in adults<\/a><\/span><\/p>\n

An EASO position statement on multidisciplinary obesity management in adults 2015<\/a><\/span><\/p>\n

European guidelines for obesity management in Adults 2015<\/a><\/span><\/p>\n

Exercise During Pregnancy – Obstetricians’ Beliefs and Recommendations Compared to American Congress of Obstetricians and Gynecologists’ 2015 Guidelines<\/a><\/span><\/p>\n

Pharmacological management of obesity an Endocrine Society clinical practice guideline. 2015<\/a><\/span><\/p>\n

Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. Canadian Task Force 2018<\/a><\/span><\/p>\n

2014<\/strong><\/span><\/p>\n

An EASO position statement on multidisciplinary obesity management in adults. 2014<\/a><\/span><\/p>\n

NICE Obesity- identifification, assessment and management. 2014<\/a><\/span><\/p>\n

2013<\/strong><\/span><\/p>\n

2013 AHA – ACC -TOS Guideline for the management of overweight and obesity in adults<\/a><\/span><\/p>\n

Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia 2013<\/a><\/span><\/p>\n

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20142013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery<\/a><\/span><\/p>\n

Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension. 2013<\/a><\/span><\/p>\n

Physical activity guidelines and preschooler’s obesity status<\/a><\/span><\/p>\n

2012<\/strong><\/span><\/p>\n

Guidelines and interventions for obesity during pregnancy. 2012<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

2026 Sarcopenic obesity: Call to action and nutritional agenda from the international clinical nutrition community International consensus on adolescent metabolic health: prevention of obesity and type 2 diabetes TOS\/OMA\/OAC Expert Guidance Statement on Obesity Pharmacotherapy: A Humbling Call to Action iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4950","page","type-page","status-publish","hentry"],"acf":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/pages\/4950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/comments?post=4950"}],"version-history":[{"count":143,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/pages\/4950\/revisions"}],"predecessor-version":[{"id":27165,"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/pages\/4950\/revisions\/27165"}],"wp:attachment":[{"href":"https:\/\/www.sochob.cl\/web1\/wp-json\/wp\/v2\/media?parent=4950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}